• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cara Therapeutics Inc

+ Add to Watchlist

CARA:US

9.9700 USD 0.0700 0.71%

As of 09:45:16 ET on 09/16/2014.

Snapshot for Cara Therapeutics Inc (CARA)

Open: 9.8700 Day's Range: 9.8700 - 9.9700 Volume: 5,405
Previous Close: 9.9000 52wk Range: 9.6305 - 23.2500 1-Yr Rtn: -

Stock Chart for CARA

No chart data available.
  • CARA:US 9.9700
  • 1D
  • 1M
  • 1Y
9.9000
Interactive CARA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CARA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0550
Est. EPS (USD) (12/2014) -0.8300
Est. PEG Ratio -
Market Cap (M USD) 223.50
Shares Outstanding (M) 22.64
30 Day Average Volume 87,051
Price/Book (mrq) 3.6302
Price/Sale (ttm) 18.4219
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/10/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CARA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CARA

Cara Therapeutics, Inc. develops therapeutics. The Company offers novel drugs for the treatment of human diseases associated with pain and inflammation. Cara Therapeutics serves customers in the United States.

Derek ChalmersPresident/CEO/Co-FounderJosef C SchoellChief Financial Officer
Robert A MedveChief Medical OfficerFrederique MenzaghiVP:R&D/Co-Founder
More Company Profile & Key Executives for CARA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • CARA News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil